FDA inspection

Shilpa Medicare Limited: FDA inspection ending Mar 10, 2023

FDA inspection 1202016 · Voluntary Action Indicated (VAI) · Hyderabad

Key facts

Inspection ID 1202016
Firm Shilpa Medicare Limited
FEI number 3019773458
Address 125 Plot No 79, 1st Floor Unit - Vii; Survey No
City Hyderabad
Country India
Fiscal year 2023
Inspection end date Mar 10, 2023
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections